- 基本信息
导师姓名:
|
钟华
|
学科代码:
|
100201
|
|
性别:
|
女
|
学科名称:
|
内科学
|
培养单位:
|
附属胸科医院
|
三级学科
|
呼吸系病
|
导师类型:
|
博士生导师
|
专业领域名称:
|
内科学 专业学位
|
联系方式:
|
eddiedong8@hotmail.com
|
专业领域代码:
|
105101
|
邮编:
|
200030
|
邮箱地址:
|
eddiedong8@hotmail.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
上海市抗癌协会胸部肿瘤专业委员会 委员
|
上海市胸科医院呼吸内科行政副主任
|
中华医学生物免疫学会理事会 理事
|
中国临床肿瘤协会 会员
|
上海抗癌协会第八届理事会 理事
|
上海市医师协会呼吸内科分会第一届委员会 委员
|
上海市医学会肿瘤靶分子专科分会 委员兼秘书
|
上海市抗癌协会肺癌分子靶向与免疫治疗专业委员会 委员
|
中国呼吸医师协会 会员
|
上海市抗癌协会第一实体肿瘤聚焦诊疗专业委员会 委员
|
美国临床肿瘤协会 会员
|
- 科研项目
19411970900 | 周围神经雪旺细胞促进小细胞肺癌侵袭转移的临床研究 | 上海市科委引导项目 |
2019-04~2022-03
|
20万元
| 课题负责人 |
2017YFC0112703 | 电磁导航系统在经胸壁诊断和治疗早期周围型肺癌中的应用 | 科学技术部 |
2017-07~2019-12
|
374万元
| 课题负责人 |
81472642 | E.muris菌经由regDC细胞PD-L1介导肺癌免疫监视的机制研究 | 国家基金委面上项目 |
2015-01~2018-12
|
64万元
| 课题负责人 |
14430723300 | 结核分枝杆菌感染调控肺部肿瘤的免疫微环境的机制研究 | 上海市科委国际合作 |
2014-07~2017-06
|
30万元
| 课题负责人 |
124119a6300 | 淋巴结内培养自体免疫细胞抑制肺癌复发转移的临床探索 | 上海市科委引导 |
2012-10~2015-09
|
20万元
| 课题负责人 |
81101722 | 小剂量持续化疗联合树突状细胞生物免疫治疗抑制肺癌侵袭转移的分子机制 | 国家自然科学基金 |
2012-01~2014-12
|
22万元
| 课题负责人 |
10ZR1428200 | 树突状细胞生物免疫治疗联合化疗抑制肺癌侵袭转移的机制探讨 | 上海市科委 |
2010-04~2012-03
|
10万元
| 课题负责人 |
06XJ21116 | 自体吞噬样细胞死亡在肺癌转移中的机制研究 | 校基金,自然科学 |
2006-10~2008-10
|
2万元
| |
- 学术论文
Jun Lu,, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqin Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu, Baohui Han
|
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for non-small cell lung cancer therapy
|
Eur Respir J
|
2019
|
53(3)
|
Jingwen Li, Shuhui Cao, Jianlin Xu,
|
De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors
|
Cancer Biol Ther
|
2019
|
1-4
|
Shuhui Cao, Jiajun Teng, Jianlin Xu, Baohui Han,
|
Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma
|
Thorac Cancer
|
2019
|
10(2):249-255
|
Shuhui Cao, Jingwen Li, Jun Lu, Runbo Zhong,
|
Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway
|
Cell Death Dis
|
2019
|
10(2):44
|
Yan Zhou, Galina V.Shurin,, Yuri L.Bunimovich, Baohui Han, Michael R.Shurin
|
Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer
|
Cancer Res
|
2018
|
78(20):5927-5939
|
Zhangguo Hu,Xiang Gu,Runbo Zhong,
|
Tumor-infiltrating CD45RO(+) memory cells correlate with favorable prognosis in patients with lung adenocarcinoma
|
J Thorac Dis
|
2018
|
10(4): 2089-2099
|
Yan Zhou, Zhangguo Hu, Shuhui Cao, Bo Yan, Jialin Qian,
|
Concomitant Mycobacterium tuberculosis infection promotes lung tumor growth through enhancing Treg development
|
Oncol Rep
|
2017
|
38(2):685-692
|
Runbo Zhong, Xiaoxiao Ge, Tianqing Chu, Jiajun Teng, Bo Yan, Jun Pei, Liyan Jiang,, Baohui Han
|
Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro
|
J Cancer Res Clin Oncol
|
2016
|
142(4):723-732
|
Yan Zhou , Yuan Li , Hong-Min Ni , Wen-Xing Ding ,
|
Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.
|
Toxicology and applied pharmacology
|
2016
|
Nov 1,310: 140-149
|
Xianxun Liu , Yan Zhou , Yuqing Lou ,
|
Knockdown of HNRNPA1 inhibits lung adenocarcinoma cell proliferation through cell cycle arrest at G0/G1 phase
|
Gene
|
2016
|
576(2), 791-797
|
, Dmitriy W. Gutkin2, Baohui Han1, Yang Ma2, Anton A. Keskinov2, Michael R. Shurin2,3 and Galina V. Shurin
|
Origin and pharmacological modulation of tumor-associated regulatory dendritic cells
|
International Journal of Cancer
|
2014
|
134:(11):2633-45
|
Runbo Zhong, Baohui Han,
|
A prospective study of the efficacy of a combination of autologous dendritis cells,cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients.
|
Tumor Biology
|
2014
|
35:987–994
|
高志强,韩宝惠,沈洁,,钟华
|
晚期非小细胞肺癌RRM1蛋白表达与吉西他滨联合顺铂化疗疗效的关系.
|
中国肺癌杂志
|
2011
|
14(4):340-344
|
Zhong RB, Teng JJ, HanBH,
|
Dendritic cells combining with cytokine-induced killer cells synergizec chemotherapy in patients with latestage non-small cell lung cancer
|
Cancer Immunology Immunotherapy
|
2011
|
160(10):1497-1502
|
钟华 ,
|
紫杉醇通过上调TAP-1, TAP-2以及消除调节性T细胞逆转肺癌免疫逃逸.
|
中国肺癌杂志
|
2010
|
10(13):937-940
|
, Baohui Han, Irina L. Tourkova, Anna Lokshin, Alan Rosenbloom, Michael R. Shurin, and GalinaV. Shurin
|
Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth
|
Clinical Cancer Research
|
2007
|
13(18), 5455-5462.
|
|